Metabolic Brain Disease

Papers
(The H4-Index of Metabolic Brain Disease is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Emerging role of non‐coding RNA in health and disease78
Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach62
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside60
Role of metals in Alzheimer’s disease58
Crossing the blood-brain barrier with AAV vectors42
Association between chronic kidney disease and Alzheimer’s disease: an update40
Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke38
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability37
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease37
β-Asarone improves learning and memory in Aβ1-42-induced Alzheimer’s disease rats by regulating PINK1-Parkin-mediated mitophagy36
Cellular and molecular pathophysiology in the progression of Parkinson’s disease36
Neuroprotective potential of Malva neglecta is mediated via down-regulation of cholinesterase and modulation of oxidative stress markers33
Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema33
Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain32
Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS32
Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway31
Subventricular zone-derived extracellular vesicles promote functional recovery in rat model of spinal cord injury by inhibition of NLRP3 inflammasome complex formation31
Paeoniflorin attenuates early brain injury through reducing oxidative stress and neuronal apoptosis after subarachnoid hemorrhage in rats28
MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax28
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action27
Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis27
Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review26
A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol25
Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice24
Pachymic acid protects against cerebral ischemia/reperfusion injury by the PI3K/Akt signaling pathway24
Circ_0006768 upregulation attenuates oxygen–glucose deprivation/reoxygenation-induced human brain microvascular endothelial cell injuries by upregulating VEZF1 via miR-222-3p inhibition24
0.10292911529541